Division of Otolaryngology, George Washington University School of Medicine and Health Sciences, Washington, DC.
Otol Neurotol. 2021 Jan;42(1):30-37. doi: 10.1097/MAO.0000000000002825.
To determine the prevalence of sensorineural hearing loss (SNHL) attributable to sickle cell disease (SCD) in the global adult population and to identify factors contributing to its severity.
Systematic Review and Meta-analysis.
We performed a comprehensive literature search for scientific articles in PubMed, Scopus, CINAHL, Web of Science, and the Cochrane Library that reported the incidence of hearing loss in populations over 18 years of age with SCD.
We identified 138 studies from the initial search, 12 of which met inclusion criteria and were utilized for data analysis. A total of 636 SCD patients and 360 controls were included in the Cochrane Review Manager 5.3 meta-analysis. There was a statistically significant increase in the prevalence of SNHL in adults with SCD compared with the general population with a cumulative risk ratio (RR) of 6.03.
This is the first systematic investigation of the relationship between SCD and SNHL in adult patients across the globe. SNHL is more prevalent in patients with SCD, specifically those of the HbSS genotype, than the general population likely due to the pathophysiology of the disease and its effects on labyrinthine microvasculature. The increased prevalence of SNHL in the adult SCD population warrants future research into the predictors of SNHL severity and merits routine audiometric monitoring of adult SCD patients.
确定全球成年人群中由镰状细胞病(SCD)引起的感觉神经性听力损失(SNHL)的患病率,并确定导致其严重程度的因素。
系统评价和荟萃分析。
我们在 PubMed、Scopus、CINAHL、Web of Science 和 Cochrane Library 中进行了全面的文献检索,以检索报告 SCD 人群中 18 岁以上人群听力损失发生率的科学文章。
我们从最初的搜索中确定了 138 项研究,其中 12 项符合纳入标准并用于数据分析。Cochrane Review Manager 5.3 荟萃分析共纳入了 636 名 SCD 患者和 360 名对照者。与一般人群相比,SCD 成人 SNHL 的患病率有统计学显著增加,累积风险比(RR)为 6.03。
这是首次对全球 SCD 成年患者的 SCD 与 SNHL 之间关系进行的系统调查。SNHL 在 SCD 患者中更为常见,尤其是 HbSS 基因型的患者,这可能是由于疾病的病理生理学及其对迷路微血管的影响。SCD 成年人群中 SNHL 的患病率增加需要进一步研究 SNHL 严重程度的预测因素,并值得对 SCD 成年患者进行常规听力监测。